Schedule 13D ownership disclosure
LANTERN PHARMA INC
Security class unavailable · CUSIP: 51654W101
Event date: 2020-06-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-20-015351
- Form type
- SC 13D
- Filer
- Lantern Pharma Inc.
- CIK
- CIK 1763950
- Filed
- Jun 19, 2020
- Reporting period
- Jun 15, 2020
- Description
- Schedule 13D beneficial ownership